Cell transplantation holds immense potential for reversing diseases that are currently
incurable and for regenerating tissues. However, poor cell survival, cell aggregation and …

Heart failure still represents the leading cause of death worldwide. Novel strategies using
stem cells and growth factors have been investigated for effective cardiac tissue …

Aims Previous studies have demonstrated improved cardiac function following myocardial
infarction (MI) after administration of endothelial progenitor cells (EPCs) into ischaemic …

Epicardial placement of mesenchymal stromal cells (MSCs) is a promising strategy for
cardiac repair post-myocardial infarction, but requires the design of biomaterials to maximise …

Objectives The clinical translation of cell-based therapies for ischemic heart disease has
been limited because of low cell retention (< 1%) within, and poor targeting to, ischemic …

One of the major problems in the treatment of cardiovascular diseases is the inability of
myocardium to self-regenerate. Current therapies are unable to restore the heart's function …

Cardiovascular diseases (CVDs) are known as the major cause of death worldwide. In spite
of tremendous advancements in medical therapy, the gold standard for CVD treatment is still …

Cyclodextrin and its derivative (CDs) are natural building blocks for linking with other
components to afford functional biomaterials. Hydrogels are polymer network systems that …

Acute myocardial infarction (AMI) has caused cardiac vascular disease to emerge in recent
years, and heart failure is the leading cause of death worldwide and modern medicine offers …

Purpose of Review: Tissue regeneration requires proper vascularization. In vivo studies
identified that the endothelial colony-forming cells (ECFCs), a subtype of endothelial …